Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 57 entries
View as:

Biomarker for Farber Disease (BioFarber)

Phase: N/A Priority: Normal
NCT ID: NCT02298634 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation

Phase: N/A Priority: Normal
NCT ID: NCT01272687 Org: User:
Start: 01/31/11 End: 06/30/17 Due: 06/30/18

Biomarker for Pompe Disease (BioPompe)

Phase: N/A Priority: Normal
NCT ID: NCT01457443 Org: User:
Start: 08/20/18 End: 12/31/21 Due: 12/31/22

Hereditary Angioedema Kininogen Assay

Phase: N/A Priority: Normal
NCT ID: NCT04091113 Org: User:
Start: 09/01/19 End: 12/31/21 Due: 12/31/22

Biomarker for Wolman Disease (BioWolman)

Phase: N/A Priority: Normal
NCT ID: NCT02383641 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

European Alpha-Mannosidosis Participant

Phase: N/A Priority: Normal
NCT ID: NCT03651245 Org: User:
Start: 08/20/18 End: 05/30/22 Due: 05/30/23

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Phase: N/A Priority: Normal
NCT ID: NCT02385162 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Phase: N/A Priority: Normal
NCT ID: NCT02654340 Org: User:
Start: 08/01/18 End: 12/30/22 Due: 12/30/23

Biomarker for Friedreich's Ataxia (BioFridA)

Phase: N/A Priority: Normal
NCT ID: NCT04548921 Org: User:
Start: 07/01/20 End: 12/31/23 Due: 12/31/24

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

Phase: N/A Priority: Normal
NCT ID: NCT03198897 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Biomarker for Hypophosphatasia Disease (BioHypophos)

Phase: N/A Priority: Normal
NCT ID: NCT02603042 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)

Phase: N/A Priority: Normal
NCT ID: NCT02298686 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01271699 Org: User:
Start: 01/31/11 End: 12/01/19 Due: 12/01/20

Establishment of Human Cellular Disease Models for Wilson Disease

Phase: N/A Priority: Normal
NCT ID: NCT03867526 Org: User:
Start: 06/19/18 End: 12/01/19 Due: 12/01/20

Biomarker for Hurler Disease (BioHurler)

Phase: N/A Priority: Normal
NCT ID: NCT02298712 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

COVID-19 Epidemic Response Study

Phase: N/A Priority: Normal
NCT ID: NCT04357496 Org: User:
Start: 05/31/21 End: 05/31/21 Due: 05/31/22

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

Phase: N/A Priority: Normal
NCT ID: NCT00414583 Org: User:
Start: 01/31/08 End: 01/31/10 Due: 01/31/11

Omics Gaucher Study: Multiomic Approach

Phase: N/A Priority: Normal
NCT ID: NCT05526664 Org: User:
Start: 10/06/22 End: 12/31/25 Due: 12/31/26

Biomarkers for Inborn Errors of Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT04098198 Org: User:
Start: 08/01/19 End: 03/11/22 Due: 03/11/23

Biomarker for Alport Syndrome (BioAlport)

Phase: N/A Priority: Normal
NCT ID: NCT02718027 Org: User:
Start: 08/20/18 End: 12/31/22 Due: 12/31/23

Epidemiological Analysis for Hereditary Angioedema Disease

Phase: N/A Priority: Normal
NCT ID: NCT03558009 Org: User:
Start: 09/01/18 End: 04/11/22 Due: 04/11/23

Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)

Phase: N/A Priority: Normal
NCT ID: NCT02298673 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Biomarker for Niemann Pick Type C Disease (BioNPC)

Phase: N/A Priority: Normal
NCT ID: NCT01306604 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Biomarker for Sly Disease (MPS VII) (BioSly)

Phase: N/A Priority: Normal
NCT ID: NCT02298699 Org: User:
Start: 08/20/18 End: 02/28/21 Due: 02/28/22

Biomarker for Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT02994030 Org: User:
Start: 08/20/18 End: 03/11/22 Due: 03/11/23